Hematologic complications of immune checkpoint inhibitors

Immune checkpoint inhibitors are a class of antineoplastic therapies that unleash immune cells to kill malignant cells. There are currently 7 medications that have been approved by the US Food and Drug Administration for the treatment of 14 solid tumors and 2 hematologic malignancies. These medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroll, Michael H., Rojas-Hernandez, Cristhiam, Yee, Cassian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Immunotherapies for Nonmalignant Hematologic Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227102/
https://www.ncbi.nlm.nih.gov/pubmed/34610113
http://dx.doi.org/10.1182/blood.2020009016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227102/
https://www.ncbi.nlm.nih.gov/pubmed/34610113
http://dx.doi.org/10.1182/blood.2020009016

Ejemplares similares